A 64-year-old with unprovoked DVT on apixaban for 6 months has low bleeding risk. To reduce recurrence long-term with less bleeding, what strategy is ...

Question

A 64-year-old with unprovoked DVT on apixaban for 6 months has low bleeding risk. To reduce recurrence long-term with less bleeding, what strategy is acceptable?

Accepted Answer

Continue reduced-dose DOAC for extended therapy

Answer

Stop anticoagulation now

Answer

Switch to aspirin only

Answer

Switch to warfarin

Answer

Add clopidogrel

us-abim MCQ (SBA): VTE-Extended Low-Dose DOAC

A 64-year-old with unprovoked DVT on apixaban for 6 months has low bleeding risk. To reduce recurrence long-term with less bleeding, what strategy is acceptable?